Browsing by Subject "myeloma"
Now showing items 1-4 of 4
-
Living with relapsed myeloma: Symptoms and self-care strategies
(Wiley, 2017-12-21)Aims and Objectives: To explore which symptoms relapsed myeloma patients experience and what self-care strategies are used.Methods: This was a qualitative study utilising focus group interviews (n=4) with relapsed myeloma ... -
Living with relapsed myeloma: symptoms and self-care strategies
(Wiley-Blackwell, 2017-12-21)Aims and Objectives: To explore which symptoms relapsed myeloma patients experience and what self-care strategies are used. Methods: This was a qualitative study utilising focus group interviews (n=4) with relapsed myeloma ... -
Phase ia/ii, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies
(Springer Nature, 2013-02-06)Panobinostat is a potent oral pandeacetylase inhibitor that leads to acetylation of intracellular proteins, inhibits cellular proliferation and induces apoptosis in leukemic cell lines. A phase Ia/II study was designed to ... -
Plerixafor for pbsc mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from europe and the usa
(Springer Nature, 2011-02-28)We describe 20 patients with myeloma and 1 with primary amyloidosis from 15 centres, all with advanced renal failure, most of whom had PBSC mobilised using plerixafor following previous failed mobilisation by conventional ...